Recent studies suggested icb-1 to act as a tumor suppressor in ovarian cancer - its knockdown accelerated growth of various ovarian cancer cell lines and led to upregulation of ovarian cancer markers like CLDN16 and KLK10 [7]. This evidence concerns the gene CLDN16 and ovarian carcinoma.